HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anand K Kondapi Selected Research

Type II DNA Topoisomerases (Topoisomerase II)

11/2017Topoisomerase IIβ and its role in different biological contexts.
5/2007Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways.
6/2006A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes.
9/2005A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.
6/2005Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives.
8/2004Design, synthesis, biological evaluation and QSAR studies of novel bisepipodophyllotoxins as cytotoxic agents.
2/2004Analysis of age dependent changes of Topoisomerase II alpha and beta in rat brain.
5/2002Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anand K Kondapi Research Topics

Disease

7Neoplasms (Cancer)
01/2020 - 06/2005
6Infections
01/2021 - 09/2005
3Parkinson Disease (Parkinson's Disease)
01/2020 - 12/2015
3HIV Infections (HIV Infection)
11/2017 - 12/2006
3Inflammation (Inflammations)
01/2017 - 05/2007
3Neuroblastoma
02/2008 - 06/2006
2Retinoblastoma (Glioblastoma, Retinal)
11/2021 - 09/2014
2Glioblastoma (Glioblastoma Multiforme)
10/2018 - 05/2007
2Acquired Immunodeficiency Syndrome (AIDS)
01/2017 - 01/2017
2Cardiotoxicity
04/2013 - 01/2012
2Astrocytoma (Pilocytic Astrocytoma)
02/2008 - 05/2007
2Poisoning
08/2004 - 05/2002
1Melanoma (Melanoma, Malignant)
02/2017
1Glioma (Gliomas)
01/2017
1Virus Diseases (Viral Diseases)
03/2016
1Liver Neoplasms (Liver Cancer)
01/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Fibrosis (Cirrhosis)
05/2010
1Lung Injury
05/2010
1Idiopathic Pulmonary Fibrosis
05/2010
1Lung Diseases (Lung Disease)
05/2010
1Cardiomyopathies (Cardiomyopathy)
08/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2009
1Genomic Instability
02/2004
1Carcinoma (Carcinomatosis)
05/2002

Drug/Important Bio-Agent (IBA)

8LactoferrinIBA
11/2021 - 01/2012
8Type II DNA Topoisomerases (Topoisomerase II)IBA
11/2017 - 05/2002
7Proteins (Proteins, Gene)FDA Link
11/2021 - 12/2006
5Pharmaceutical PreparationsIBA
01/2020 - 01/2012
5trioctyl phosphine oxide (TOPO)IBA
04/2013 - 08/2004
3Protein Isoforms (Isoforms)IBA
03/2016 - 06/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2013 - 01/2012
3apotransferrinIBA
04/2013 - 01/2012
2Etoposide (VP 16)FDA LinkGeneric
11/2021 - 08/2004
2Carboplatin (JM8)FDA LinkGeneric
11/2021 - 09/2014
2CurcuminIBA
01/2021 - 05/2010
2Temozolomide (Temodar)FDA LinkGeneric
10/2018 - 01/2017
2RotenoneIBA
05/2016 - 12/2015
2DNA (Deoxyribonucleic Acid)IBA
06/2006 - 08/2004
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2021
1Tenofovir (Viread)FDA Link
01/2021
1Small Interfering RNA (siRNA)IBA
10/2018
1Aurora Kinase BIBA
10/2018
1Fluorouracil (Carac)FDA LinkGeneric
02/2017
1Phosphotransferases (Kinase)IBA
01/2017
1pyridineIBA
01/2017
1Drug CombinationsIBA
01/2017
1Dicumarol (Dicoumarol)FDA Link
01/2017
1FlavonoidsIBA
05/2016
1Polymethyl Methacrylate (Sol)IBA
09/2014
1Coloring Agents (Dyes)IBA
04/2013
1P-2 (P 2)IBA
04/2013
1lactoferrin receptorsIBA
01/2013
1IronIBA
01/2012
1Therapeutic UsesIBA
01/2012
1EnzymesIBA
12/2010
1Type I DNA Topoisomerases (Topoisomerase I)IBA
12/2010
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2010
1indium-bleomycinIBA
05/2010
1CollagenIBA
05/2010
1PeroxidesIBA
02/2008
1nordihydroguaretic acidIBA
05/2007
1Peptides (Polypeptides)IBA
05/2007
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
05/2007
1Immunologic Factors (Immunomodulators)IBA
12/2006
1Staphylococcal Protein A (Protein A)IBA
12/2006
1Glycoproteins (Glycoprotein)IBA
12/2006
1Cell ExtractsIBA
09/2005
1PoisonsIBA
06/2005
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
05/2002
1Organometallic CompoundsIBA
05/2002

Therapy/Procedure

3Drug Therapy (Chemotherapy)
10/2018 - 12/2010
1Radiotherapy
02/2017
1Therapeutics
05/2010